Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-30 Purchase | 2026-02-02 4:05 pm | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 5,700 | $0.89 | $5,073 | 39,133 (Direct) | View |
| 2025-12-10 Purchase | 2025-12-11 08:31 am | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 5,000 | $1.165 | $5,825 | 32,733 (Direct) | View |
| 2024-10-11 Purchase | 2024-10-16 08:30 am | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 50 | $2.4638 | $123 | 19,368 (Direct) | View |
| 2024-10-10 Purchase | 2024-10-15 08:30 am | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 450 | $2.61 | $1,175 | 19,318 (Direct) | View |
| 2024-03-13 Purchase | 2024-03-14 8:54 pm | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 1,010 | $7.29 | $7,363 | 16,513 (Direct) | View |
| 2022-07-26 Purchase | 2022-07-26 4:38 pm | WINDTREE THERAPEUTICS INC | WINT | Hamill John P. SVP & CFO | 3,000 | $0.3666 | $1,100 | 72,800 (Direct) | View |
| 2021-04-16 Purchase | 2021-04-19 07:49 am | WINDTREE THERAPEUTICS INC | WINT | Hamill John P. SVP & CFO | 1,000 | $2.0669 | $2,067 | 3,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-12 Option Award | 2026-03-16 6:06 pm | N/A 2036-03-12 | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 50,475 | $0 | 83,908 (Direct) | View |
| 2025-03-27 Option Award | 2025-03-31 4:31 pm | N/A 2035-03-28 | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 16,825 | $0 | 36,193 (Direct) | View |
| 2024-03-28 Option Award | 2024-03-28 5:59 pm | N/A 2024-03-28 | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 16,825 | $0 | 32,328 (Direct) | View |
| 2023-02-27 Option Award | 2023-02-27 6:37 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 1,000 | $5.25 | 14,493 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-30 5:21 pm | N/A 2033-01-30 | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | 809,637 | $0 | 809,637 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-07 5:52 pm | 2022-05-31 2032-03-04 | WINDTREE THERAPEUTICS INC | WINT | Hamill John P. SVP & CFO | 165,900 | $0 | 169,400 (Direct) | View |